XML 80 R69.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
May 06, 2025
Feb. 14, 2025
Feb. 13, 2025
Nov. 07, 2024
Nov. 06, 2024
Jun. 24, 2024
Jan. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Mar. 06, 2025
Mar. 05, 2025
Dec. 20, 2024
Subsidiary or Equity Method Investee [Line Items]                          
Share price                     $ 0.10 $ 0.10  
Issuance of stock, value               $ 14,308,300          
Private placement transaction       $ 2,669,250       $ 14,300,000   $ 4,900,000      
Deduction costs of offering       $ 330,750                  
Cancellation of restricted stock, shares               0 56        
Shares of common stock were exercised                      
Reverse stock split one-for-twenty reverse stock split                        
Net loss (income) attributable to noncontrolling interests               $ 3,611 $ 12,248        
Nobility Healthcare LLC [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Subsidiary ownership percentage               49.00%          
Net loss (income) attributable to noncontrolling interests               $ 3,611 $ 12,248        
Nobility Healthcare LLC [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Equity method investment ownership percentage               51.00%          
Officers [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Common stock issuance granted             2,750            
Vesting drescription             Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates.            
New Employees [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Common stock issuance granted             1,260            
New Employees [Member] | Minimum [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Vesting period             1 year            
New Employees [Member] | Maximum [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Vesting period             2 years            
Private Placement [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Issuance of stock, shares           59,761              
Share price           $ 50.20              
Pre-funded unit price           $ 0.001              
Common Stock [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Issuance of stock, shares               392,500          
Share price                         $ 1.00
Issuance of stock, value               $ 392          
Common stock issuance granted                 4,010        
Cancellation of restricted stock, shares                 56        
Series B Warrants [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Shares of common stock were exercised               189,689          
Shares of common stock were exercised, value               $ 3,793          
Fair value of warrant derivative liability               $ 1,989,806          
Prefunded Warrants [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Exercise price               $ 0.001          
Shares of common stock were exercised               4,907,500          
Underwriting Agreement [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Net proceeds from offering   $ 13,480,000                      
Underwriting Agreement [Member] | Over-Allotment Option [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Issuance of stock, value   $ 14,308,300                      
Underwriting Agreement [Member] | Common Stock [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Offering percentage   15.00%                      
Underwriting Agreement [Member] | Common Stock [Member] | Over-Allotment Option [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Issuance of stock, shares   300,000                      
Underwriting Agreement [Member] | Series A Warrants [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Offering percentage   15.00%                      
Underwriting Agreement [Member] | Series A Warrants [Member] | Underwriting Discount [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Share price   $ 0.00001                      
Underwriting Agreement [Member] | Series A Warrants [Member] | Over-Allotment Option [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Share price   $ 0.00001                      
Warrant shares   750,000                      
Underwriting Agreement [Member] | Series B Warrants [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Offering percentage   15.00%                      
Underwriting Agreement [Member] | Series B Warrants [Member] | Underwriting Discount [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Share price   $ 0.00001                      
Underwriting Agreement [Member] | Series B Warrants [Member] | Over-Allotment Option [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Share price   $ 0.00001                      
Warrant shares   750,000                      
The Securities Purchase Agreement [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Private placement transaction           $ 2,900,000              
Securities Purchase Agreement [Member] | Private Placement [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Issuance of stock, shares         40,419                
Issuance of stock, value         $ 3,600,000                
Private placement transaction         $ 3,000,000.0                
Aegis Capital Corp [Member] | Underwriting Agreement [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Issuance of stock, shares     392,500                    
Share price     $ 3.00                    
Aggregate purchase price percentage   7.00%                      
Legal fees percentage   1.00%                      
Aegis Capital Corp [Member] | Underwriting Agreement [Member] | Series A Warrants [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Exercise price     3.75                    
Aegis Capital Corp [Member] | Underwriting Agreement [Member] | Series B Warrants [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Exercise price     $ 6.00                    
Aegis Capital Corp [Member] | Underwriting Agreement [Member] | Prefunded Warrants [Member]                          
Subsidiary or Equity Method Investee [Line Items]                          
Issuance of stock, shares     4,607,500                    
Share price     $ 2.98                    
Exercise price     $ 0.001